Acquiring a De-SPACed Company: Board Considerations, Capitalization Structure, Warrants, Tax Issues
Note: CPE credit is not offered on this program
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE webinar will examine the issues associated with M&A transactions involving a de-SPAC target company, including special fiduciary concerns of directors and officers when the offered price is below initial valuations, navigating the complex capital structures of de-SPAC companies, how to assess current and potential liabilities of the target, and potential tax ramifications of a de-SPAC acquisition.
Outline
- De-SPAC companies as potential targets in the current market
- Board considerations
- Assessing shareholder support
- Navigating complex capital structures
- Earnout shares
- Warrants
- Tax issues: Up-C entity structures, tax receivable agreements
- Risk of litigation or investigation
Benefits
The panel will review these and other key issues:
- What factors have made de-SPAC companies desirable acquisition targets in today's market?
- What are some particular concerns of de-SPAC directors in considering the sale of the company?
- How might earnout shares and warrants affect the purchase price and the closing process in a de-SPAC acquisition?
- How should existing or threatened litigation be addressed in a de-SPAC acquisition?
Faculty
Jenny Hochenberg
Partner
Freshfields Bruckhaus Deringer
Ms. Hochenberg focuses her practice on mergers and acquisitions, corporate governance and shareholder activism defense.... | Read More
Ms. Hochenberg focuses her practice on mergers and acquisitions, corporate governance and shareholder activism defense. She is a thought leader and frequent speaker on emerging trends in M&A and corporate governance law and is currently Vice Chair of the ABA's Acquisition of Public Companies Subcommittee. Ms. Hochenberg has worked on some of the biggest and most transformative M&A transactions of our time, both purely US as well as cross-border. Her clients have included Afterpay, Atlas Air Worldwide, bp, Cable One, Canadian National Railway, Cincinnati Bell, City Brewing, CommScope, Crown Castle, Exyte, GW Pharmaceuticals, Johnson & Johnson, Light & Wonder, Moda Operandi, NCR, Novartis, Pitney Bowes, Scientific Games, Time Warner, US Foods, Viatris and Yahoo.
CloseBrayden Koslowsky
Attorney
Freshfields Bruckhaus Deringer
Mr. Koslowsky is an associate in our M&A practice in New York.
| Read MoreMr. Koslowsky is an associate in our M&A practice in New York.
CloseDaniel Lee
Managing Director
Moelis & Company
Mr. Lee is a Managing Director at Moelis & Company where he provides strategic and financial advice to clients on... | Read More
Mr. Lee is a Managing Director at Moelis & Company where he provides strategic and financial advice to clients on M&A transactions and chairs the Firm’s Fairness and Valuation Committee. He has approximately 20 years of investment banking experience with expertise in public company and special committee M&A transactions across a range of industries.
Close